Glenmede Trust’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-230
Closed -$13K 2654
2015
Q3
$13K Buy
+230
New +$13K ﹤0.01% 2033
2015
Q1
Sell
-1,100
Closed -$69K 2449
2014
Q4
$69K Buy
+1,100
New +$69K ﹤0.01% 1658
2014
Q3
Sell
-2,400
Closed -$111K 2458
2014
Q2
$111K Buy
2,400
+100
+4% +$4.63K ﹤0.01% 1365
2014
Q1
$91K Sell
2,300
-1,980
-46% -$78.3K ﹤0.01% 1453
2013
Q4
$161K Buy
4,280
+480
+13% +$18.1K ﹤0.01% 1227
2013
Q3
$123K Buy
3,800
+800
+27% +$25.9K ﹤0.01% 1299
2013
Q2
$67K Buy
+3,000
New +$67K ﹤0.01% 1439